Pharmacotherapy for Pulmonary Hypertension in Infants with Bronchopulmonary Dysplasia: Past, Present, and Future

Approximately 8–42% of premature infants with chronic lung disease of prematurity, bronchopulmonary dysplasia (BPD), develop pulmonary hypertension (PH). Infants with BPD-PH carry alarmingly high mortality rates of up to 47%. Effective PH-targeted pharmacotherapies are desperately needed for these i...

Descripción completa

Detalles Bibliográficos
Autores principales: Fike, Candice D., Aschner, Judy L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141152/
https://www.ncbi.nlm.nih.gov/pubmed/37111262
http://dx.doi.org/10.3390/ph16040503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141152/
https://www.ncbi.nlm.nih.gov/pubmed/37111262
http://dx.doi.org/10.3390/ph16040503

Ejemplares similares